PANEL ASSESSMENT

Clariifi assessment of the complete somatic panel analysis of new patients

DOUBLE-REVIEW

Double review by network of nationally recognized precision oncology experts

EXPERT ANNOTATION

Expert annotation of the complete molecular profile including:

  • Pathogenicity (including variants of uncertain application)
  • Therapeutic relevance (both off-label and relevant trials)
  • Credentialed molecular characteristics
  • Immunotherapy, HRD, NER, Lynch, tumor molecular burden, etc.

EXPERT TUMOR DNA REVIEW

Therapeutic suggestions for known variants Proposed action for variants of uncertain treatment value report with information to support letters of medical necessity and/or clinical trial options

Benefits of ClariifiSelect™

PATIENT / FAMILIES

Confidence that no stone has been unturned in the quest for treatment options, due to the nationally renown experts supporting your oncologist.

PRACTICE MANAGERS

Standardize precision oncology output across testing platforms, clear ‘value-based’ medication selection (ask about Clariifi Practice Revenue Calculator), efficient use of clinician time. Increased patient/family satisfaction.

ONCOLOGISTS

Clear suggestions for therapy selection, priority of treatments, and medical necessity support revealed by precision oncology experts reviewing your patients tumor panel sequencing reports.

INSURER / BENEFITS MANAGERS

Expert adjudication results in clear, objective, and science-driven choices of treatment, especially in areas where there are not guidelines.